The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty-seven patients

Key Findings

• ●Largest cohort study: 57 patients with HUV
• ●Angioedema in 51%, musculoskeletal 82%, ocular 56%, pulmonary 19%, renal 14%
• ●Evaluated treatment efficacy via time-to-treatment failure
• ●Hydroxychloroquine, colchicine, and corticosteroids as first-line therapy

Referenced in (1 disease)